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Moringa oleifera Lam. is a highly valued medicinal plant in India, especially Kerala. In the present study,
antioxidant activity of aqueous extract of leaves of  M. oleifera was determined both  in-vitro and  in-
vivo. Male Wistar rats of 3 age groups- 6, 12, and 18 months old were used for in-vivo analysis. In vitro
anti-proliferative effect of the extract was carried out in Dalton’s Lymphoma Ascites (DLA) Cells. LCMS-
QTOF analysis of the extract was also done to determine the bioactive components present in the
extract. Antioxidant activity of M. oleifera leaf showed an IC 50 value of 10.47 μg/ml  and whereas for
standard  drug,  ascorbic  acid,  it  was  19.52  μg/ml.  In-vivo  analysis  of  lipid  peroxidation  showed  a
significant reduction of lipid peroxidation in the brains of 12 and 18-months old treated groups. Up to
75% mortality of DLA cancerous cells was observed  in-vitro in different concentrations of  M. oleifera
leaf water extract in a dose-dependent manner, demonstrating its anti-proliferative property.  LCMS-
QTOF analysis revealed the presence of emodin-8-glucoside in the extract. Molecular docking analysis
(Auto  Dock  Vina)  of  emodin-8-glucoside  with  six  cancer  related  proteins  showed  highest  binding
affinity with AKT-1 with a binding score of -10.4 kcal/mol, also showed good affinity with NF-kB (p65),
Stat-3,  Bcl-2,  Bcl-xl  and c-FLIP.  This  study helps to choose healthy diet practices to overcome free
radical onslaught and cancerous cell proliferation especially in the later stages of life. This can also
pave way for the emergence of diet based therapeutic cure for cancer.
Introduction
Studies of pharmacological applications of medicinal
plants used in the diet entails a new arena of research.
Several  plants  are  being  investigated  for  their
pharmacological potential. There is need for research
to understand the nontoxicity and economic viability
of  these  medicinal  plants  being  used  for  various
pharmacological  interventions,  especially  to  fight
against cancer (1).
Moringa  oleifera  Lam.  (Family  Moringaceae),  is
also  called  as  horseradish  tree,  drumstick  tree  in
English and in Sanskrit,  it  is  called as Shigru. It has
been an ingredient of our diet for several centuries. Its
reported effects include: antitumor (2, 3), hypotensive
(4),  antifungal  (5),  antispasmodic  and  anti-
inflammatory  activities  (6).  Bioactive  compounds
present  in  M. oleifera include  vitamins,  carotenoids,
polyphenols,  flavonoids,  essential  amino  acids  and
phenolic acids. All the parts of the tree are edible and
possesses  various  pharmacological  actions  and
therefore, used in the Indian traditional medicine to
cure to various ailments; and is called ‘miracle tree’ (7-
9).  
In  the  present  study,  M.  oleifera leaf  aqueous
extract  was  investigated  for  its  antioxidant  activity
and  anti-proliferative  activity.  LCMS  QTOF  analysis
was  also  conducted  to  determine  the  bioactive
components  present  in  the  extract  and  in  silico
molecular docking analysis was also performed using
emodin-8-glucoside  with  six  anti-cancer  targets.
Emodin-8-glucoside is  a  potential  candidate  for anti-
cancerous activity as it is an anthraquinone and has
got a striking chemical resemblance to anthracyclines
as clinically well-established anticancer drug (10-12).
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Plant material collection and authentication
M. oleifera leaves were collected during the months
of  April-May  2018 from  homestead  garden
(10 ̊01’53.5” N 76 ̊29’15.2” E), Ernakulam, Kerala, India.
and was shade dried for 7 days and powdered, sieved
and stored in sterile glass bottles in refrigerator until
use.  The  plant  material  was  authenticated
(authentication  no.  NISCAIR/RHMD/Consult/
2019/3403-04) by CSIR-NISCAIR RHMD (Raw Material
Herbarium  and  Museum,  New  Delhi).  The
identification was done on the basis of macroscopic
studies  of  the  sample  followed  by  scrutiny  of
literature  and  matching  the  sample  with  authentic
samples  deposited  in  the  RHMD.  DNA  barcoding
(matk gene;  GenBank  sequence  ID:  MK165485.1)  of
the  sample  was  done  at  Rajiv  Gandhi  Centre  for
Biotechnology,  Thiruvananthapuram,  Kerala,  India.
The voucher specimen (No. 486) and Herbarium was
deposited  at  Dept.  of  Botany,  St.  Albert’s  College
Herbarium (SAC) Ernakulam, Kerala, India. 
Plant extract preparation
Soxhlet extraction was carried out by taking 50 gm of
dried  M.  oleifera leaf  powder  in  500  ml  distilled
water.  The  extract  was  concentrated  using  rotary
evaporator  (Hahnvapor  HS2005V,  Hahnshin
Scientific) and lyophilised under vacuum. The extract
thus obtained was used for further studies.
Percent yield
The  percent  yield  was calculated  after  running  the
Soxhlet extraction process for a fixed period of time
(48 hrs). It was calculated by taking the weight of the
extract obtained after lyophilization with the initial
weight  of  the  leaf  powder taken for  the  extraction
process, using the equation:
 Weight of dry extract × 100
% 𝑦𝑖𝑒𝑙𝑑 =
Weight of powdered leaves
Preliminary phytochemical screening 
Qualitative  analysis  of  Moringa oleifera leaf  extract
was  done  for  qualitative  identification  of  various
phytochemical  constituents  such  as  carbohydrates,
tannins,  saponins,  flavonoids,  quinones,  glycosides,
cardiac  glycosides,  terpenoids,  phenols,  coumarins,
steroids,  phytosteroids  and anthraquinones  with
standard methods (13-15).
Antioxidant activity in-vitro 
Antioxidant  activity of  the  lyophilized  aqueous
extract of  M. oleifera  leaf  in various concentrations
ranging  from  20  μg/ml  to  200μg/ml was  tested  by
DPPH  method  (16).  Ascorbic  acid  was  used  as  the
standard.  Statistical  analysis  (one-way ANOVA) and
IC50  values  were  calculated  using  GraphPad  Prism
(Ver 5.0).
In-vivo lipid peroxidation study
Healthy  male  Wistar  rats  belonging  to  three  age
groups; 6 months old, 12 months old and 18 months
old  were  selected  for  the  study. After  the
acclimatization  period  of  two  weeks,  the  animals
were divided randomly in to control and treatment
groups of 6 animals each. IAEC approval for the study
was  obtained  from  the  College  of  Veterinary  and
Animal  Sciences,  Mannuthy,  Thrissur,  Kerala,  India
(Order  No.  Acad(3)/6554/04,  dated  27/09/18).
Lyophilized  aqueous extract  of M. oleifera  leaf  was
given orally at a dosage of 200 mg/kg body weight (17,
18)  for 30 days to all  the treatment group animals.
The  corresponding  control  animals  received  same
volume  of  distilled  water  orally  as  that  of  the
treatment group.  During the study, the animals were
housed  in  standard-sized  polypropylene  cages  and
were fed with  water  and commercial  pelleted  feed
ad-libitum.   On  the  31st day,  all  the  animals  were
sacrificed by CO2  euthanasia and brain was removed
immediately  and  weighed.  The  brain  sample  was
homogenized  in  normal  saline  and  centrifuged  at
3000 rpm. The supernatant thus obtained was used
for lipid peroxidation assay. Lipid peroxidation was
determined by the standard method (19). To 1 ml of
the sample, 2 ml 1:1:1 TBA – TCA – HCl (Acetic acid –
15%;  Thiobarbituric  acid  in  hot  distilled  water  –
0.38% and HCl – 0.25N) reagent was added and mixed
well and heated in a boiling water bath for 15 min.
After  cooling,  the  mixture  was  centrifuged  at  3200
rpm  for  15  min.  The  supernatant  was  taken  and
absorbance  was  read  at  535  nm  in  Perkin  Elmer
UV/VIS/NIR  spectrometer  Lambda  750.  Lipid
peroxidation  was  expressed  as  nmoles  of  MDA/mg
tissue. Tetra-methoxy propane (4.8 Mm) was used as
standard. 
In-vitro anti-proliferative study
The  lyophilized  aqueous  extract  of  M.  oleifera leaf
was  tested  for  its  anti-proliferative  property  in
Dalton’s  Lymphoma  Ascites  cells  (DLA)  (20).  The
tumour cells aspirated from the peritoneal cavity of
tumour  bearing  mice  were  washed  thrice  with
Phosphate  Buffer  Saline  (PBS).  Cell  viability  was
determined by trypan blue exclusion method. Viable
cell suspension (1×106 cells in 0.1 ml) was added to
tubes containing various concentrations (10 μg/ml to
200  μg/ml)  of  lyophilized  aqueous  extract  of  M.
oleifera leaf  and the volume was made up to  1  ml
using  PBS.  Control  tubes  contained  only  cell
suspension.  These  assay  mixtures  were  then
incubated for 3 hrs at  37  °C. Cell  viability  after the
drug treatment was assessed by mixing with 0.1 ml
1% of trypan blue and keeping for 2-3 min. Then it
was  loaded  on  the  counting  chamber  of
haemocytometer  and  the  number  of  dead  and live
cells  were determined.  The number of  stained  and
unstained  cells  were  counted  separately  and
percentage  cytotoxicity  was  determined.  The  study
was  conducted  in  triplicate  and  the  statistical
analysis  (One  Way  ANOVA)  was  carried  out  using
GraphPad Prism (Ver 5.0). 
LCMS QTOF analysis (liquid chromatography 
mass spectrometry - quadrupole time-of-flight)
LCMS  QTOF  analysis  was  done  over  an  LCMS
instrument  (Agilent  Technologies,  USA)  after  the
digestion  and  desalting  of  protein  part  from  the
lyophilized aqueous extract of  M. oleifera. Details of
the instrumentation are as follows:  Hypersil  GOLD
C18  100  x  2.1  mm-3 MICRON,  Hip  Sampler,  Binary
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pump and Q-TOF.  For  MS Q-TOF (G6550A),  the  ion
source  used  was  Dual  AJS  ESI.  The  eluent  was
monitored  by  electrospray  ion  mass  spectrometer
(ESI-MS) under positive-ion mode. ESI was conducted
by using a fragmentor voltage of 125 V, skimmer 65
V, gas temperature at 250 °C and nebulizer at 35 psi.
Running  time  was  30  min.  The  mode  of  sample
application  to  Hip  Sampler  was  by  injection  with
needle wash and the injection volume was 10.00 µL.
The high-pressure limit in the binary pump (G4220B)
was 1200 bar and the flow rate were 0.3 ml/min. Data
analysis was processed with Agilent Mass Hunter and
acquisition  method  used  was  30
mins_+ESI_10032014_MS-MS.m. The  composition  of
solvents is given in (Table  1). The analysis was done
at  Sophisticated  Analytical  Instrumentation  Facility
(SAIF) at IIT Bombay, India.
In-silico analysis
Molecular  docking  analysis  was  done  to  determine
the anti-proliferative potential of emodin-8-glucoside
against  six cancer signalling proteins such as AKT1
(PDB ID:3O96), Bcl-2 (PDB ID: 5JSN), NF-kB (p65) (PDB
ID: IK3Z), Stat-3 (PDB ID: 6NUQ), Bcl-xl (PDB ID: 2YXJ)
and  c-FLIP  (PDB  ID:  3H13).  PDB  structure  of  the
proteins  were  downloaded  from  RCSB-PDB
(https://www.rcsb.org/)  and  the  structure  of  the
ligand emodin-8-glucoside (PubChem ID: 99649) was
downloaded  from  PubChem  database.  Protein
preparation  were  done  using  PyMOL (Schrodinger)
software,  where  heteroatoms  were  removed  and
hydrogen  atoms  were  added  to  all  the  proteins.
Docking analysis was done using AutoDock Vina (21)
and  the  docked  poses  were  visualized  using
Discovery Studio visualizer. Grid box parameters for
AKT-1 was X = 6.299, Y = -7.951 and Z = 17.275, for Bcl-
2; X = -3.509, Y = -5.511 and Z = 58.241, for NF-kB; X =
15.566, Y= -0.545 and Z = -0.955, for stat-3; X = -2.217,
Y = 19.174 and Z = 24.597, for Bcl-xl; X = -7.138, Y = -
21.012 and Z = 1.74 and for cFlip;  X = 35.338, Y = -
34.637 and Z = -14.5.  
Statistical analysis 
The  statistical  significance  was determined by one-
way ANOVA with Tukey’s  multiple  comparison test
using  GraphPad  Prism  Ver.  5.  P  value  <0.05  was
considered significant.
Results 
Percent yield and preliminary phytochemical 
screening 
Percent  yield for  lyophilized aqueous  extract  of  M.
oleifera leaf  was  30%  (Table  2).  Preliminary
phytochemical  screening  of  the  extract  showed the
presence  of  flavonoids,  carbohydrates,  coumarins,
saponins and terpenoids (Table 3).
Antioxidant activity in-vitro
The  lyophilized  aqueous  extract  of  M.  oleifera  leaf
showed higher antioxidant activity than the ascorbic
acid  at  both  the  concentration  of  10  μg/ml  (48.20±
0.4%)  and  20  μg/ml  (82±0.5%),  while  at  the
concentration  of  50  μg/ml,  the  extract  showed
93.20±0.3%  whereas  the  ascorbic  acid  showed
94.54±0.6% inhibition of DPPH radical. The IC50 value
for the M. oleifera leaf extract was 10.47 μg/ml while
it was 19.52 μg/ml for ascorbic acid (Table 4).
Lipid peroxidation in-vivo
The  treatment  with  M.  oleifera leaf  water  extract
significantly  (p<0.05) reduced  lipid  peroxidation  in
the brains of 12- and 18-months old rats after 30 days
treatment. But the 6-months old treated group did not
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Table 1.  Solvent composition of LCMS-QTOF Analysis
Solvent name Channel 2 solvent %
A 0.1% FA in water 100.0 % Water V.02 95%
B 90% ACN +10% H2O+ 0.1% FA 100.0 % Acetonitrile 
V.02
5%
Table 2. percent yield of aqueous extract of M. oleifera leaf
Name of the extract Percent yield (%)
M. oleifera leaf aqueous extract 30±2 %
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Table 4. Percentage inhibition of DPPH radical by M. oleifera leaf












IC50 10.47 μg/ml 19.52μg/ml
show any significant change when compared to the
control group (Table 5). 
In-vitro anti-proliferative activity
Various concentrations of the lyophilized aqueous of
M. oleifera ranging from 10 μg/ml to 200 μg/ml extract
were  studied  and  a  substantial  suppression  of  75
±0.4%  and  65±0.5  %  of  DLA  cancerous  cells  was
obtained at a concentration of 200 μg/ml and 100 μg/
ml,  respectively.  A  concomitant  decrease  in  the
activity  was  also  observed  as  the  concentration
decreased. According to Tukey’s honest significance
test,  all  the  treatment  groups  except  between  20
μg/ml and 10 μg/ml groups were statistically  highly
significant (P<0.05) (Table 6). 
LCMS -QTOF analysis
LCMS  analysis  (Table  7,  Fig.  1  &  2)  revealed  the
presence of emodin 8 glucoside along with 11-amino-
undecanoic  acid,  some
glycerophosphoethanolamines  (GPEtn)  and  fatty
acids with glycerol were also identified. 
Molecular docking analysis
Molecular  docking  studies  revealed  the  binding
affinity of emodin-8-glucoside (Fig.  3a-f)  with AKT-1,
NF-kB (p65), Stat-3, Bcl-2, Bcl-xl and c-FLIP. With AKT-
1 emodin-8-glucoside had the most negative binding
affinity.  The binding affinity  was -10.5 kcal/mol  for
AKT-1and forBcl-xl and stat3, it showed -8.3 kcal/mol
and  -7.6  kcal/mol,  respectively.   Lowest  binding
affinity was for Bcl-2 with a binding score of -7.2 kcal/
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Table 5. Levels of TBARS in the brain tissue of Wistar rats treated
with  M.  oleifera  leaf  water  extract  at  a  dosage  of  200
mg/kg body wt. (Mean ± SEM)  (n=6)
Age (months)
Lipid Peroxidation (nM / mg tissue)




One-way  ANOVA  with  repeated  measures  Tukey’s  multiple
comparison test using Graph Pad Prism (Ver 5.0). Groups with same
superscript did not vary significantly (P<0.05).




M. oleifera leaf water
extract (μg/ml)
Anti-proliferative activity 







One-way  ANOVA  with  repeated  measures  Tukey’s  multiple
comparison test using Graph Pad Prism (Ver 5.0). Groups with same
superscript did not vary significantly (P<0.05).
Table 7. Result of LCMS QTOF analysis of M. oleifera leaf aqueous extract
No. Compound Label RT Mass Formula Hits
1 Emodin 8-glucoside 5.795 432.1 C21 H20 O102 8
2 His Ser His 8.069 379.15 C15 H21 N7 O5 10
4 11-amino-undecanoicAcid 9.517 201.173 C11 H23 N O2 3
6 GPEtn(20:0/17:0)[U] 16.21 761.58 C42 H84 N O8 P 9
7 GPEtn(22:0/26:0)[U] 17.09 915.773 C53 H106 N O8 P 5
8 1-hexadecanoyl-2-(9Zhexadecenoyl)-3octadecanoylsn-glycerol 18.46 832.74 C53 H100 O6 10
9 TG(16:1(9Z)/20:0/20:3(8Z,11Z,14Z))[iso6] 18.49 910.7 C59 H106 O6 10
10 1-heptadecanoyl-(9Z,12Zheptadecadienoyl)-3-octadecanoyl-sn-glycerol 18.51 858.76 C55 H102 O6 10
11 1-hexadecanoyl-2-(11Z-octadecenoyl)-sn-glycerol 19.04 594.51 C37 H70 O5 10
12 TG(17:1(9Z)/17:2(9Z,12Z)/22:3(10Z,13Z,16Z))[iso6] 19.86 905.76 C59 H102 O6 10
Fig. 1. Chromatogram of LC/MS Analysis of M. oleifera leaf water
extract.
Fig. 2. MSMS Spectrum of Emodin-8-glucoside.
mol. With cFLIP and NF-kB(p65), emodin-8-glucoside
showed a binding  affinity  of  -7.3  kcal/mol  and -7.4
kcal/mol, respectively (Table 8, Fig. 3a-f). 
Discussion
Percent  yield  and  preliminary  phytochemical
screening 
The percent yield of an extract defines the efficiency
of the extraction process and here we got 30% yield
when  water  was  used  as  the  solvent  for  the
extraction  process  (Table  2).  High  yields  of  water
extract  accounts  for  hydrophilic  nutrients,
carbohydrates amino acids, water soluble secondary
metabolites,  nutrients,  electrolytes and phenolics  to
some  extent  etc.,  which  are  insoluble  or  slightly
soluble  in  the presence of ethanol  (22).  It  was  also
reported a percent yield of 37.83% with water  (23).
Preliminary phytochemical  screening  analysis  were
done to determine various phytoconstituents present
in M. oleifera leaf  aqueous  extract. All  parts  of  M.
oleifera have been used for medicinal purposes and it
is imminent that the phytoconstituents present in the
plant  is  responsible  for  the  medicinal  value. One
study  reported  the  presence  of  alkaloids,  saponins,
tannins, flavonoids and sugars from aqueous extracts
of  M.  oleifera leaf  (24). In  the  present  study  also,
water  extract  showed  the  presence  of  flavonoids,
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Table 8. Showing the binding energy and interactions of Emodin-8 glucoside with various cancer targets
Targets Binding Energy Interactions 
AKT-1 -10.5
Van der Waal’s interactions: Gln-79, Tyr-272 and Ile-290, conventional hydrogen bond: Thr-211, carbon-
hydrogen bond: Ser-205, pi-anion interaction: Asp-292, Pi-Pi stacked interaction: Trp-80, alkyl and Pi-alkyl 
interactions: Leu-264, Lys-268 and Val-270 and Leu-210
NF-kB -7.4 Van der Waal’s interaction: Ser-261, Ala-264, Thr-292, Asp-293, Arg-297 and Glu-299, conventional 
hydrogen bonds: Gln-263, Asp-291 and His-296, alkyl and pi-alkyl interactions: Pro-265 and Pro-290
Stat-3 -7.6
Van der Waal’s interaction: Gln-247, Ala-250, Cys-251, Ile-252, Gly-253, Glu-324, Arg-325, Gln-326, Cys-328, 
Arg-335, Pro-336, Trp-474, conventional hydrogen bond and Pi-anion interaction: Asp-334, carbon 
hydrogen bond with Ser-514, alkyl and pi-alkyl interactions: Pro-256. Unfavourable acceptor-acceptor 
interaction Pro-333
Bcl-2 -7.2
Van der Waal’s interaction: Asp-111, Met-115, Glu-136, Arg-139, Asn-143, and Phe-153, conventional 
hydrogen bond: Asp-140, pi-sigma with Phe-112, Pi-Pi T-shaped interaction: Tyr-108 and Phe-104 and Pi-
alkyl interaction: Ala-149
Bcl-xl -8.3
Van der Waal’s interaction: Phe-97, Asp-107, Phe-131, Asp-133 and Phe-146, conventional hydrogen bonds: 
Leu-130 and Arg-139, carbon-hydrogen bond and Pi-anion interaction: Glu-129, alkyl and pi-alkyl 
interactions: with Ala-104, Phe-105, Leu-108, Ala-142 and Ala-149
Fig. 3. a-f. 2D Images of binding of emodin-8-glucoside with AKT-1 (a), Bcl-2 (b), Bcl-xl (c), c-FLIP (d), NF-kB (p65) (e), Stat-3 (f). 
carbohydrates,  coumarins,  phenols,  saponins,
terpenoids, steroids and phytosteroids (Table 2).
In-vitro antioxidant activity
M. oleifera is reported to contain greater amounts of
flavonoids than any other vegetable or fruit (25). In
the  present  study,  M.  oleifera leaf  aqueous  extract
exhibited  93.20%  inhibition  of  DPPH  radical  at  a
concentration  of  50  μg/ml  and  the  IC50  value  was
found  to  be  10.47 μg/ml  (Table  4).  Most  of  the
flavonoids reported in plants are water soluble and
are  responsible  for  antioxidant  activity  in  water
extracts  thus  providing protection against  oxidative
damage  (26).  In  the  present  study  too,  greater
antioxidant  activity  comparable  to  vitamin  C  was
obtained with the M. oleifera leaf extract.  M. oleifera
leaves can be considered as dietary supplement for
healthy  ageing  and  to  prevent  age  associated  free
radical onslaught, especially, in the brain. Sreelatha
and Padma (26) reported that water extracts of both
the  tender  leaves  and mature  leaves  of  M. oleifera
have  significant  protective  effect  against  oxidative
damage  by  reducing  lipid  peroxidation,  inhibiting
superoxide anion, nitric oxide and complete reversal
of H2O2 induced DNA damage. Earlier in-vitro studies
also reported protective effect of extracts of Moringa
leaves against oxidative stress (27, 28). Similar results
were also reported by Charoensin, 2014 in M. oleifera
methanol and dichloromethane extracts (22).  
Lipid peroxidation in-vivo
The  finding  that  the  extract  significantly  reduced
lipid peroxidation in 12 months old and 18 months
old experimental  group animals shows the efficient
antioxidant property of Moringa leaves (Table 5). The
lipid  peroxidation  expressed  in  malondialdehyde
(MDA) levels can be considered as a direct measure
of  cellular  oxidative  damage  (29),  the  significant
decrease in MDA levels in aged animals was due to
the antioxidant role played by the extract. Since lipid
peroxidation is one of the major causes of ageing, its
prevention offers a better protective measure against
many  neurodegenerative  diseases  also.  Protection
against lipid peroxidation can also maintain cellular
integrity and, thus, can restore cellular homeostasis
during  the  process  of  ageing.  Highly  significant
increase in lipid peroxidation was seen with age of
the rats which were used as the control in the present
study. It is to be noted that all the treated groups of
Wistar rats showed similar lipid peroxidation levels
of 6 months old control animal irrespective of the age
of  the  treated  animals.  The  bioactive  components
having  antioxidant  property can be responsible  for
scavenging free radicals  and chelation of  transition
metal ions,  which accelerates lipid peroxidation via
Fenton reaction (30). Treatment with M. oleifera leaf
hydroalcoholic  extracts  has  been  reported  to
significantly  reduce  lipid  peroxidation  in  cortex,
hippocampus and striatum (31).  Pre-treatment with
M. oleifera  leaf methanol extract at a dosage of 250
and 500 mg/kg significantly  attenuated chlorpyrifos
induced  lipid  peroxidation  in  rat  brain  and  also
reduced  neuronal  degeneration  (32).  The  bioactive
component  emodin-8-glucoside  identified  via  LCMS
QTOF (vide  infra)  could  be  one  potent  free  radical
scavenger  in  M. oleifera  extract  and as  responsible
for the reduction of lipid peroxidation in the present
study.  The  present  study,  thus  establishes  the
antioxidant  activity  of  M.  oleifera through  in-vivo
studies too. 
In-vitro anti-proliferative activity
Even though all  parts  of  the  M. oleifera plant  have
been  extensively  studied  for  their  respective  anti-
cancer  property,  only  few  compounds  have  been
identified  from  water  extract,  compared  to
methanolic  or  ethanolic  extracts.  Tiloke  and
coworkers (33) have done antiproliferative effect of
M.  oleifera crude  aqueous  leaf  extract  on  human
esophageal cancer cells (SNO) and observed that the
extract significantly increased lipid peroxidation and
DNA fragmentation in SNO cells. They found that the
induction of apoptosis was mediated by the increase
in phosphatidylserine externalization, caspase-9 and
caspase-3/7  activities  and  decreased  ATP  levels.  In
addition, the extract significantly increased both the
expression of Smac/DIABLO protein and cleavage of
poly [ADP-ribose] polymerase 1 (PARP-1), resulting in
an increase in the 24 kDa fragment (33).  According to
one study,  M. oleifera  leaf  extract was more potent
than callus extract in reducing the viability of HeLa
cervix  cancer  cells  in  a  concentration-dependent
manner  (34).  Our study is in line with these results
that we also got a concomitant increase in cancerous
cell  death  as  the  concentration  of  the  extract
increases.  It  was  found  that  at  200  μg/ml
concentration  of  the  extract  showed  75%  death  of
cancerous cells in the medium and 65% death at 100
μg/ml concentration (Table 5).  However,  it was  also
reported that  the crude aqueous extract  of  the leaf
exerts antiproliferative effects in A549 lung cells by
increasing oxidative  stress,  DNA fragmentation and
inducing apoptosis  (35). The morphological  changes
of the HeLa cells treated with various concentrations
of  M. oleifera  extract were typical  of  apoptosis  and
proposed the involvement of mitochondria also (36).
Hence, we conducted molecular docking studies with
emodin-8-glucoside  with  anti-apoptotic  as  well  as
signaling proteins (vide infra). 
LCMS-QTOF  analysis  and  molecular  docking
study
Compounds like Emodin 8-glucoside, His Ser His, 11-
amino-undecanoic  acid,  GPEtn  (20:0/17:0)[U],  GPEtn
(22:0/26:0)[U],  1-hexadecanoyl-2-(9Zhexadecenoyl),
3octadecanoylsn-glycerol,    TG(16:1(9Z)/20:0/20:3(8Z,




were detected from lyophilized aqueous extract of M.
oleifera leaf  (Table  7).  Emodin-8-glucoside  is  an
anthraquinone  and  has  got  a  striking  chemical
resemblance  to  anthracyclines,  which  are  clinically
well-established  anticancer  drugs  (10-12)  and  since
no reports of anti-proliferative activity of emodin-8-
glucoside  from  M.  oleifera was  reported,  it  was
further studied here by in silico method. 
Molecular  docking  analysis  was  done  to  state
emodin-8-glucosides  could  be  one  among the  other
several  components  present  in the  extract  showing
anti-cancer  property.  There  are  also  reports  that
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suggest  that  aloe  -  emodin  can  be  a  potential
candidate  for  anti-cancer  therapy  (37).  Recently  it
was  also  reported  that  the  emodin inhibits  human
cancer  cell  invasiveness  by  antagonizing  P2X7
receptor (38). Emodin-8-glucoside was docked against
proteins involved in crucial cell signalling processes
such as AKT1,  NF-kB (p65),  Stat3 and anti-apoptotic
proteins such as Bcl-2, Bcl-xl and c-Flip (Table 8,  Fig.
3a-f). 
AKT  also  called  protein  kinase  B  (PKB),  is  a
member  of  PI3K/AKT  signalling  pathway.  AKT
isoforms  (AKT1,  AKT2  and  AKT3)  are  often
upregulated in cancer cells (39). AKT1 is ubiquitously
expressed and directly responsible for growth factor
mediated  cell  survival,  prevention  of  apoptosis  by
inactivating pro-apoptotic proteins and angiogenesis
(40–42). Importantly, tumour suppressor protein p53
is  also  regulated  by  AKT  signalling  and  hence  the
oncogenic  activation of  p53 through AKT results  in
rapid  destabilization  of  p53  and  results  in
antiapoptotic signal (43, 44). Hence, AKT is an active
target  for  anti-cancer  therapy  and  AKT  inhibitors
were  found  to  supress  cancer  progression.  In  this
study,  emodin-8-glucoside  showed  high  affinity  to
bind  with  AKT1  with  a  binding  energy  of
-10.5kcal/mol, showing its potential interactions with
AKT1,  possibly  leading  to  its  inactivation.  In  this
binding  of  emodin-8-gludoside  with  AKT-1,  van der
Waal’s interactions were formed with Gln-79, Tyr-272
and Ile-290,  conventional  hydrogen bond with  Thr-
211,  carbon-hydrogen  bond  with  Ser-205,  pi-anion
interaction  with  Asp-292,  Pi-Pi  stacked  interaction
with Trp-80, alkyl and Pi-alkyl interactions were with
Leu-264,  Lys-268 and Val-270 and Leu-210 (Table  8,
Fig. 3).
NF-kB transcription factor family consists of five
subunits;  p65  (RelA)  is  one  among  them.  NF-kB
signalling  pathway  is  involved  in  diverse  cellular
processes  including  cell  proliferation  and
differentiation,  immunity,  stress,  inflammation  and
apoptosis (45–48). Altered NF-kB pathways are often
associated with different forms of malignancies and
therefore  NF-kB  inhibition  is  an  unquestionable
target  for  cancer  treatment.  Also,  several  NF-kB
inhibitors  are  not  effective  as  an  anti-cancer  agent
since  its  exact  mechanism  of  action  is  unknown.
Emodin-8-glucoside  binds  with  p65  with  a  binding
score  of  -7.3  kcal/mol.  The  interactions  formed
include van der Waal’s interaction with Ser-261, Ala-
264,  Thr-292,  Asp-293,  Arg-297  and  Glu-299,
conventional  hydrogen bonds  Gln-263,  Asp-291 and
His-296, alkyl and pi-alkyl interactions were formed
with Pro-265 and Pro-290 (Table 8, Fig. 3b).
Stat3  (signal  transducer  and  activator  of
transcription3)  is  activated  inappropriately  and the
downstream  expression  of  target  genes  are  the
hallmark of many solid and haematological cancers.
Untimely activation of the gene that are activated by
stat3 signalling cascade are hallmarks of cancer (49).
So, the inhibitors of stat3 are also possible targets for
cancer  drug  research.  Emodin-8-glucoside  showed
high affinity to bind with stat3 with a binding score
of -7.6 kcal/mol and the interactions formed were of
van der Waal’s interaction with Gln-247, Ala-250, Cys-
251,  Ile-252, Gly-253, Glu-324,  Arg-325,  Gln-326, Cys-
328,  Arg-335,  Pro-336,  Trp-474,  conventional
hydrogen  bond  and  Pi-anion  interaction  with  Asp-
334,  carbon hydrogen bond with Ser-514, alkyl and
pi-alkyl  interactions  with  Pro-256.  Unfavourable
acceptor-acceptor interaction was there with Pro-333
(Table 8, Fig. 3c). Further studies may help to identify
the possible mechanism of action. 
The  antiapoptotic  proteins  Bcl-2  and  Bcl-xl
function by preventing either the oligomerization of
BAK-BAX  by  directly  binding  to  BH3  domain  of
activator  BH3  only  proteins  or  they  bind  with
activated  BAK-BAX  and  induce  conformational
changes,  thus  preventing  apoptosis  (50–52).  Bcl2
overexpression  is  also  reported  in  many  forms  of
leukaemia  and  lymphomas.  Development  of  potent
Bcl-2  antagonists  as  anti-apoptotic  and  anti-cancer
agents  are  being  investigated  as  therapeutic
approach to treat cancer (53-55). Emodin-8-glucoside
is a natural compound from M. oleifera leaf having a
binding score of -7.2 kcal/mol with Bcl-2 and -8.3 kcal/
mol with Bcl-xl, and showing high potential to bind
with  these  anti-apoptotic  proteins.  This  compound
targets both Bcl-2 and Bcl-xl hence, it is an important
lead  compound  for  anti-cancer  therapy.  Following
interactions  were  formed  between  emodin-8-
glucoside and Bcl-2; van der Waal’s interaction with
Asp-111, Met-115, Glu-136, Arg-139, Asn-143, and Phe-
153,  conventional  hydrogen bond was formed with
Asp-140,  pi-sigma  with  Phe-112,  Pi-Pi  T-shaped
interaction  with  Tyr-108  and  Phe-104  and  Pi-alkyl
interaction was with Ala-149 (Table 8,  Fig.  3d). With
Bcl-xl,  emodin-8-glucoside  formed  van  der  Waal’s
interaction at Phe-97, Asp-107, Phe-131, Asp-133 and
Phe-146, conventional hydrogen bonds were formed
with  Leu-130  and  Arg-139,  carbon-hydrogen  bond
and Pi-anion interaction with Glu-129, alkyl and pi-
alkyl  interactions  were  with  Ala-104,  Phe-105,  Leu-
108, Ala-142 and Ala-149 (Table 8, Fig. 3e). 
c-FLIP is a cellular FLICE like inhibitory protein
and is an anti-apoptotic protein which inhibits TNF-α,
Fas-L  and  TNF-related  apoptosis  inducing  ligand
(TRAIL)  induced  apoptosis  and  also  chemotherapy
induced  apoptosis  in  malignant  cells.  Binding  of
cFLIP to caspase-8 or -10 prevents the formation of
Death  Inducing  Signalling  Complex  (DISC)  and
activation of caspase cascade (56). Upregulation of c-
FLIP  is  often  associated  with  various  forms  of
malignancies  (57).  In  the  present in-silico study,
emodin-8-glucoside showed high affinity to bind with
cFLIP with a binding score of -7.4 kcal/mol. Binding of
emodin-8-glucoside  with  c-FLIP  resulted  in  the
formation  of  van  der  Waal’s  interaction  with  Ser-
318,Val-362,  Ser-363,  Thr-407,  Ala-408,  Met-410,  Lys-
460, and Lys-462, Pi-Pi stacked interaction with Tyr-
464, alkyl and pi-alkyl interactions with Trp-466 and
Leu 405. Unfavourable acceptor-acceptor interaction
was also noted with ala-459 and Asp-409 (Table 8, Fig.
3f).
An  inhibitor  with  potential  for  binding  with
several  anti-cancer  targets  are  always  the  most
promising  compound  for  anti-cancer  therapy (58).
Emodin-8-glucoside is one such compound obtained
from  M.  oleifera leaf  aqueous  extract  showing
binding affinity with AKT1, NF-kB (p65), Stat3, Bcl-2,
Bcl-xl and cFLIP in the present docking study. Thus, it
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is a compound capable to bind with multiple cancer
targets. Based on our results and available literature,
the  anti-cancer  property  of  M.  oleifera leaf  water
extract is possibly due to the presence of emodin-8-
glucoside compound.  The compound attracts further
attention  towards  unravelling  its  novel  action  and
possible mechanism in its purified form, apart from
crude extract as a potent antineoplastic drug.
Conclusion
Moringa  oleifera  leaf  lyophilized  aqueous  extract
contained  bioactive  components,  which  showed
potent antioxidant property  in-vitro and  in-vivo, and
anti-cancer  property  in-vitro and  in-silico.  With  the
support of our in-vitro and in-silico results, we report
emodin-8-glucoside  as  one  of  the  bioactive
components in the  Moringa leaf  water extract with
potent  anti-proliferative  activity.  M.  oleifera  leaves
can be a nutritive diet component to prevent cancer
in the light of our observation and various its other
established pharmacological actions.
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